178 related articles for article (PubMed ID: 35505287)
1. The prevalence of Fabry disease in a statewide chronic kidney disease cohort - Outcomes of the aCQuiRE (Ckd.Qld fabRy Epidemiology) study.
Mallett A; Kearey PJ; Cameron A; Healy HG; Denaro C; Thomas M; Lee VW; Stark SL; Fuller M; Wang Z; Hoy WE
BMC Nephrol; 2022 May; 23(1):169. PubMed ID: 35505287
[TBL] [Abstract][Full Text] [Related]
2. The Ckd. Qld fabRy Epidemiology (aCQuiRE) study protocol: identifying the prevalence of Fabry disease amongst patients with kidney disease in Queensland, Australia.
Mallett A; Kearey P; Cameron A; Healy H; Denaro C; Thomas M; Lee VW; Stark S; Fuller M; Hoy WE
BMC Nephrol; 2020 Feb; 21(1):58. PubMed ID: 32087678
[TBL] [Abstract][Full Text] [Related]
3. Screening for Fabry disease in patients undergoing dialysis for chronic renal failure in Turkey: identification of new case with novel mutation.
Okur I; Ezgu F; Biberoglu G; Tumer L; Erten Y; Isitman M; Eminoglu FT; Hasanoglu A
Gene; 2013 Sep; 527(1):42-7. PubMed ID: 23756194
[TBL] [Abstract][Full Text] [Related]
4. Results of Fabry Disease Screening in Male Pre-End Stage Renal Disease Patients with Unknown Etiology Found Through the Platform of a Chronic Kidney Disease Education Program in a Northern Taiwan Medical Center.
Lin CJ; Chien YH; Lai TS; Shih HM; Chen YC; Pan CF; Chen HH; Hwu WL; Wu CJ
Kidney Blood Press Res; 2018; 43(5):1636-1645. PubMed ID: 30380558
[TBL] [Abstract][Full Text] [Related]
5. Screening of Fabry disease in patients with chronic kidney disease in Japan.
Nagata A; Nasu M; Kaida Y; Nakayama Y; Kurokawa Y; Nakamura N; Shibata R; Hazama T; Tsukimura T; Togawa T; Saito S; Sakuraba H; Fukami K
Nephrol Dial Transplant; 2021 Dec; 37(1):115-125. PubMed ID: 34282462
[TBL] [Abstract][Full Text] [Related]
6. Screening of Fabry Disease of patients in renal replacement therapy in a population from Lazio (Italy).
Marrone G; Angelico R; Di Lauro M; Sargentini E; Manzia TM; Tisone G; Mitterhofer AP; Della Morte Canosci D; Tesauro M; Di Daniele N; Noce A
Eur Rev Med Pharmacol Sci; 2023 Apr; 27(7):3134-3141. PubMed ID: 37070916
[TBL] [Abstract][Full Text] [Related]
7. The Prevalence of Fabry Disease in Patients with Chronic Kidney Disease in Turkey: The TURKFAB Study.
Turkmen K; Guclu A; Sahin G; Kocyigit I; Demirtas L; Erdur FM; Sengül E; Ozkan O; Emre H; Turgut F; Unal H; Karaman M; Acıkel C; Esen H; Balli E; Bıtırgen G; Tonbul HZ; Yılmaz MI; Ortiz A
Kidney Blood Press Res; 2016; 41(6):1016-1024. PubMed ID: 28006774
[TBL] [Abstract][Full Text] [Related]
8. The prevalence of Fabry disease among 1009 unrelated patients with hypertrophic cardiomyopathy: a Russian nationwide screening program using NGS technology.
Savostyanov K; Pushkov A; Zhanin I; Mazanova N; Trufanov S; Pakhomov A; Alexeeva A; Sladkov D; Asanov A; Fisenko A
Orphanet J Rare Dis; 2022 May; 17(1):199. PubMed ID: 35578305
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of Fabry disease in dialysis patients: Western Australia Fabry disease screening study - the FoRWARD study.
Jahan S; Sarathchandran S; Akhter S; Goldblatt J; Stark S; Crawford D; Mallett A; Thomas M
Orphanet J Rare Dis; 2020 Jan; 15(1):10. PubMed ID: 31931840
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of Fabry disease in a Turkish population with chronic kidney patients.
Tomar ÖK; Bal AZ; Şirali SK; Duranay M; Korucu B; Güz G; Akdağ Sİ
Int Urol Nephrol; 2023 Jun; 55(6):1629-1634. PubMed ID: 36725792
[TBL] [Abstract][Full Text] [Related]
11. [Screening Test of Fabry Disease in Patients with Renal Replacement Therapy in the City of Modena].
Alfano G; Ganda N; Cerami C; Mori G; Fontana F; Cappelli G
G Ital Nefrol; 2018 Mar; 35(2):. PubMed ID: 29582965
[TBL] [Abstract][Full Text] [Related]
12. Screening for Fabry disease among 619 hemodialysis patients in Saudi Arabia.
Alhemyadi SA; Elawad M; Fourtounas K; Abdrabbou Z; Alaraki B; Younis S; Nawaz Z; Alqurashi S; Mohamed S
Saudi Med J; 2020 Aug; 41(8):813-818. PubMed ID: 32789421
[TBL] [Abstract][Full Text] [Related]
13. Screening of family members of chronic kidney disease patients with Fabry disease mutations: a very important and underrated task.
Sodré LSS; Huaira RMNH; Colugnati FAB; Carminatti M; Braga LSS; Coutinho MP; Fernandes NMDS
J Bras Nefrol; 2021; 43(1):28-33. PubMed ID: 32930322
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of Fabry disease in patients with chronic kidney disease: A systematic review and meta-analysis.
Linares D; Luna B; Loayza E; Taboada G; Ramaswami U
Mol Genet Metab; 2023 Dec; 140(4):107714. PubMed ID: 37918171
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of Fabry disease in patients in hemodialysis in the Madrid community.
Corchete Prats E; González-Parra E; Vega A; Macías N; Delgado M; Fernández M; Sánchez RJ; Álvarez L; Miranda RJ; Vian J; López V; Mérida E; Pereira M; Sapiencia D; Andrés N; Muñoz P; Gil Y; Sánchez M; Cases C; Gil B; García A; Sainz V; Alexandru S; Pampa S; López M; Flor JC; Estrada PN; Berlanga JR; Zamora R; Sánchez R; Rodríguez-Osorio L; Fraile C; Caravaca-Fontán F; Moratilla C; Cabré C; Furaz K; Nieto L; Villaverde MT; Tapia CG; Cedeño S; Castellano S; Valdés E; Ferreira M; Martínez P; Sanz M; Sánchez M; Ríos F; Palomo S; Serrano ML; Blanco A; Espinel L; Tornero F; Herrero JA
Nefrologia (Engl Ed); 2023; 43(4):435-441. PubMed ID: 36564230
[TBL] [Abstract][Full Text] [Related]
16. Fabry disease in hemodialysis patients in southern Brazil: prevalence study and clinical report.
Porsch DB; Nunes AC; Milani V; Rossato LB; Mattos CB; Tsao M; Netto C; Burin M; Pereira F; Matte U; Giugliani R; Barros EJ
Ren Fail; 2008; 30(9):825-30. PubMed ID: 18925518
[TBL] [Abstract][Full Text] [Related]
17. Nationwide screening for Fabry disease in unselected stroke patients.
Tomek A; Petra R; Paulasová Schwabová J; Olšerová A; Škorňa M; Nevšímalová M; Šimůnek L; Herzig R; Fafejtová Š; Mikulenka P; Táboříková A; Neumann J; Brzezny R; Sobolová H; Bartoník J; Václavík D; Vachová M; Bechyně K; Havlíková H; Prax T; Šaňák D; Černíková I; Ondečková I; Procházka P; Rajner J; Škoda M; Novák J; Škoda O; Bar M; Mikulík R; Dostálová G; Linhart A;
PLoS One; 2021; 16(12):e0260601. PubMed ID: 34905550
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of Cerebral Microbleeds in Patients with Fabry Disease.
Kono Y; Wakabayashi T; Kobayashi M; Ohashi T; Eto Y; Ida H; Iguchi Y
J Stroke Cerebrovasc Dis; 2016 Jun; 25(6):1320-5. PubMed ID: 26987491
[TBL] [Abstract][Full Text] [Related]
19. Screening for Fabry disease in male patients with end-stage renal disease in western France.
Vigneau C; Germain DP; Larmet D; Jabbour F; Hourmant M;
Nephrol Ther; 2021 Jun; 17(3):180-184. PubMed ID: 33994139
[TBL] [Abstract][Full Text] [Related]
20. Preliminary Screening Results of Fabry Disease in Kidney Transplantation Patients: A Single-Center Study.
Yılmaz M; Uçar SK; Aşçı G; Canda E; Tan FA; Hoşcoşkun C; Çoker M; Töz H
Transplant Proc; 2017 Apr; 49(3):420-424. PubMed ID: 28340804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
